1 week Ago By Defense World Staff
JPMorgan Chase & Co. raised its stake in InMode Ltd. ( NASDAQ:INMD – Free Report ) by 4.
4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,084,241 shares of the healthcare company’s stock after acquiring an additional 45,638 shares during the quarter. JPMorgan Chase & Co.
owned approximately 1.56% of InMode worth $18,107,000 as of its most recent filing with the Securities & Exchange Commission. Other institutional investors and hedge funds have also recently modified their holdings of the company.
National Bank of Canada FI lifted its holdings in InMode by 6.2% during the third quarter. National Bank of Canada FI now owns 9,985 shares of the healthcare company’s stock valued at $169,000 after purchasing an additional 579 shares during the last quarter.
Harvey Capital Management Inc. raised its holdings in InMode by 1.4% during the 4th quarter.
Harvey Capital Management Inc. now owns 51,490 shares of the healthcare company’s stock valued at $860,000 after acquiring an additional 700 shares during the period. Thrivent Financial for Lutherans lifted its position in shares of InMode by 6.
1% during the fourth quarter. Thrivent Financial for Lutherans now owns 12,586 shares of the healthcare company’s stock worth $210,000 after acquiring an additional 721 shares in the last quarter. Franklin Resources Inc.
boosted its holdings in shares of InMode by 4.6% in the third quarter. Franklin Resources Inc.
now owns 17,559 shares of the healthcare company’s stock worth $292,000 after acquiring an additional 768 shares during the period. Finally, Farther Finance Advisors LLC grew its position in shares of InMode by 26.2% in the fourth quarter.
Farther Finance Advisors LLC now owns 5,555 shares of the healthcare company’s stock valued at $93,000 after purchasing an additional 1,154 shares in the last quarter. 68.04% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades A number of brokerages recently issued reports on INMD. Barclays increased their price objective on InMode from $26.00 to $29.
00 and gave the stock an “overweight” rating in a report on Wednesday, February 5th. Needham & Company LLC restated a “hold” rating on shares of InMode in a research report on Wednesday. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock.
According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $22.25. InMode Stock Performance NASDAQ:INMD opened at $14.
88 on Friday. InMode Ltd. has a 52-week low of $13.
68 and a 52-week high of $19.85. The stock has a fifty day moving average of $18.
01 and a 200 day moving average of $17.67. The firm has a market capitalization of $1.
04 billion, a price-to-earnings ratio of 6.33 and a beta of 1.96.
About InMode ( Free Report ) InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
See Also Five stocks we like better than InMode Compound Interest and Why It Matters When Investing JPMorgan is a Buy, if You Can Handle The Volatility Ride Out The Recession With These Dividend Kings United States Steel’s Crash: An Unmissable Buying Opportunity How to Start Investing in Real Estate Rocket Lab Stock: Weathering the Storm, Time for a Comeback? Want to see what other hedge funds are holding INMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InMode Ltd. ( NASDAQ:INMD – Free Report ).
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter ..
